chronic lymphocytic leukemia

You have access
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
BARTOSZ PULA, ELZBIETA ISKIERKA-JAZDZEWSKA, MONIKA DLUGOSZ-DANECKA, AGNIESZKA SZYMCZYK, MAREK HUS, AGNIESZKA SZEREMET, JOANNA DROZD-SOKOLOWSKA, ANNA WASZCZUK-GAJDA, JAN M. ZAUCHA, JADWIGA HOLOJDA, WERONIKA PISZCZEK, PAWEL STECKIEWICZ, MALGORZATA WOJCIECHOWSKA, MICHAL OSOWIECKI, WANDA KNOPINSKA-POSLUSZNY, MAREK DUDZINSKI, DARIA ZAWIRSKA, EDYTA SUBOCZ, JANUSZ HALKA, ANDRZEJ PLUTA, RYSZARD WICHARY, BEATA KUMIEGA, BOZENA K. BUDZISZEWSKA, WOJCIECH JURCZAK, EWA LECH-MARANDA, KRZYSZTOF GIANNOPOULOS, TADEUSZ ROBAK and KRZYSZTOF JAMROZIAK

Anticancer Research July 2020, 40 (7) 4059-4066; DOI: https://doi.org/10.21873/anticanres.14403
You have access
mTORC1/2 Inhibitor Served as a More Ideal Agent Against the Growth of Mouse Lymphocytic Leukemia Both In Vitro and In Vivo
HUI-FEN LIAO, YOU-ZHU LIN, CHIH-CHIA YU, TZONG-SHYUAN TAI, SHIH-KAI HUNG, CHING-CHIEH YANG and YU-CHIEH SU

Anticancer Research September 2019, 39 (9) 4829-4835; DOI: https://doi.org/10.21873/anticanres.13668
You have access
Overexpression of Galectin-3 in Chronic Lymphocytic Leukemia Is Associated With 17p Deletion: A Short Report
ZUZANA MICHALOVÁ, MATÚŠ ČOMA, MIROSLAVA KIČOVÁ, JULIANA GABZDILOVÁ, KINGA DEDINSKÁ, TOMÁŠ GUMAN, MARTINA HÁJIKOVÁ, DOMINIKA VESELINYOVÁ, MÁRIA GIERTLOVA, PETER GÁL and MAREK ŠARIŠSKÝ

Anticancer Research June 2019, 39 (6) 2805-2810; DOI: https://doi.org/10.21873/anticanres.13408
You have access
Expression and Effects of Ligand-activated Estrogen Receptors in Chronic Lymphocytic Leukemia
MOHAMMAD SHARIF HASNI and KONSTANTIN YAKIMCHUK

Anticancer Research January 2019, 39 (1) 167-172; DOI: https://doi.org/10.21873/anticanres.13093
You have access
Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)
BARTOSZ PUŁA, BOŻENA KATARZYNA BUDZISZEWSKA, JUSTYNA RYBKA, LIDIA GIL, EDYTA SUBOCZ, MONIKA DŁUGOSZ-DANECKA, DARIA ZAWIRSKA, ANNA WASZCZUK-GAJDA, ELŻBIETA ISKIERKA-JAŻDŻEWSKA, AGNIESZKA KOPACZ, AGNIESZKA SZYMCZYK, JAROSŁAW CZYŻ, EWA LECH-MARAŃDA, KRZYSZTOF WARZOCHA and KRZYSZTOF JAMROZIAK

Anticancer Research May 2018, 38 (5) 3025-3030;
You have access
Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia
GORDON T. BOLGER, ALBERT LICOLLARI, AIMIN TAN, RICHARD GREIL, LISA PLEYER, BRIGITTA VCELAR, MUHAMMAD MAJEED and PETER SORDILLO

Anticancer Research January 2018, 38 (1) 121-130;
You have access
Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?
SOTIRIOS SACHANAS, GERASSIMOS A. PANGALIS, MARIA MOSCHOGIANNIS, XANTHI YIAKOUMIS, EFSTATHIOS KOULIERIS, PANTELIS TSIRKINIDIS, CHRISTINA KALPADAKIS and DIMITRA RONTOGIANNI

Anticancer Research June 2017, 37 (6) 3277-3280;
You have access
Tumor Protein 53 Gene Mutations Without 17p13 Deletion Have No Significant Clinical Implications in Chronic Lymphocytic Leukemia. Detection of a New Mutation
PANAGIOTIS T. DIAMANTOPOULOS, STAVROULA SAMARA, PANAGOULA KOLLIA, NEFELI GIANNAKOPOULOU, MARIA SOFOTASIOU, FANI KALALA, ELINA KODANDREOPOULOU, PANAGIOTIS ZERVAKIS, THEODOROS VASSILAKOPOULOS, MARINA SIAKANTARIS, MARINA MANTZOURANI, MARIA ANGELOPOULOU, MARIE-CHRISTINE KYRTSHONIS, PENELOPE KORKOLOPOULOU, EFSTATHIOS PATSOURIS and NORA-ATHINA VINIOU

Anticancer Research May 2017, 37 (5) 2387-2391;
You have access
Malakoplakia of the Urinary Bladder in a Patient with Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: A Case Report
SOTIRIOS SACHANAS, GERASSIMOS A. PANGALIS, PETROS KAROUZAKIS, EFSTATHIOS KOULIERIS, MARIA MOSCHOGIANNIS, CHRISTINA KALPADAKIS, XANTHI YIAKOUMIS and DIMITRA RONTOGIANNI

Anticancer Research September 2016, 36 (9) 4759-4762;
You have access
Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL
INGO G.H. SCHMIDT-WOLF, CHRISTOPH PLASS, JOHN C. BYRD, KATHRIN FREVEL, TORSTEN PIETSCH and ANDREAS WAHA

Anticancer Research September 2016, 36 (9) 4515-4519;

Main menu

User menu

Search

chronic lymphocytic leukemia

Pages